S 1702
Access to Prescription Digital Therapeutics Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 9:01 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Access to Prescription Digital Therapeutics Act of 2025 aims to expand access to healthcare by allowing Medicare and Medicaid to cover prescription digital therapeutics – software applications designed to prevent, manage, or treat medical conditions. The bill establishes a framework for payment methodologies for these therapies, requiring the Secretary of Health and Human Services to develop a system that considers factors like list prices and ongoing use. It also mandates reporting requirements for manufacturers regarding payment rates, distribution volumes, and user numbers, with potential civil penalties for non-compliance.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.